Affymax Inc

(AFFY)

By |

Profile

Affymax Inc is a development-stage biopharmaceutical company, engaged in developing novel peptide-based therapeutics for the treatment of life-threatening conditions. The company's product includes OMONTYS, an injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis.

Contact Information

Website: www.affymax.com
Email: investors@affymax.com
Main Phone: +1 650 812-8700
Address: 630 Fifth Avenue
Address 2: Suite 2260
State: NY
City / Town: New York
Country: USA
Postal Code: 10020

Issuer Information

Exchange: OTO
CEO: Richard M. Brenner
Employees: 2
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.01525 $ -0.00165 (-9.76%)
Last Price 0.01525 Change $ -0.00165 Change % -9.76 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.01525 High 0.01525 Low 0.0136 Prev Close 0.0169
Last Trade Volume 30,020 52 Wk Hi 0.05 52 Wk Low 0.011
Market Cap 571,724 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 37,490,095.00 EPS (TTM) 0.06 PE Ratio 0.30 Exchange OTCPK
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
John P. Walker 1,000
John P. Walker 1,000
Last 10 Sell Shares
John P. Walker 1,000
John P. Walker 1,000
John A. Orwin 1,000
Jeffrey H. Knapp 1,000
Jeffrey H. Knapp 1,000
Kathleen D. Laporte 1,000
John A. Orwin 1,000
Robert F. Venteicher 1,000
Jeffrey H. Knapp 1,000
Jeffrey H. Knapp 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 1 1 1 1
Low Target Price Estimate 1 1 1 1
Mean Target Price Estimate 1 1 1 1
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 08/05/13 08/05/13 08/05/13 08/05/13
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 3